EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Markers for Early Diagnosis and Post-operative Recurrence Monitoring of Bladder Cancer

Zhao Yang, Nan Zhang, Zongyi Shen, Suhang Bai, Mengran Shi, Liqi Yin, Jieqiao Li, Xiaolin Lei, Changyuan Yu, Chong Li

Cancer Plus · 2020

DOI: 10.18063/cp.v2i1.270 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Plus, 2020. Verfasst von Zhao Yang und 9 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The diagnosis and management of bladder cancer (BC) are high complex due to cancer heterogeneity among patients. Thus, biomarkers play pivotal roles in the diagnosis, prognosis determination, and planning of therapeutic intervention of BC. With years of research and discovery, many candidate markers for BC have emerged. The alterations of nucleosides, proteins, post-translational modifications, and cells are the candidate markers for early diagnosis and post-operative recurrence monitoring of BC. This review mainly discusses the recent progresses in the proteins and nucleosides markers for diagnosis and recurrence monitoring of BC. In the detection of BC, some potential nucleoside-based markers have been reported, including telomerase reverse transcriptase (TERT) gene, microsatellite, and chromosome instability, whereas the protein markers include bladder tumor antigen, nuclear matrix protein family (Nuclear matrix protein 22), fibrin/fibrin degradation product, and aberrantly glycosylated integrin α3β1. Besides, the performance of diagnostic methods based on these markers are reviewed. The sensitivity and specificity of candidate markers and detection methods of BC are compared. In summary, this review provides invaluable information about the early diagnosis and recurrence of BC, which guides the development and improvement of novel markers for early diagnosis and post-operative recurrence monitoring of BC in future.

Zitieren

APA

Yang, Z., Zhang, N., Shen, Z., Bai, S., Shi, M., Yin, L., Li, J., Lei, X., Yu, C., & Li, C. (2020). Markers for Early Diagnosis and Post-operative Recurrence Monitoring of Bladder Cancer. Cancer Plus. https://doi.org/10.18063/cp.v2i1.270

Vancouver

Yang Z, Zhang N, Shen Z, Bai S, Shi M, Yin L, et al. Markers for Early Diagnosis and Post-operative Recurrence Monitoring of Bladder Cancer. Cancer Plus. 2020. doi:10.18063/cp.v2i1.270

BibTeX
@article{Yang2020,
  author = {Yang, Zhao and Zhang, Nan and Shen, Zongyi and Bai, Suhang and Shi, Mengran and Yin, Liqi and Li, Jieqiao and Lei, Xiaolin and Yu, Changyuan and Li, Chong},
  title = {Markers for Early Diagnosis and Post-operative Recurrence Monitoring of Bladder Cancer},
  journal = {Cancer Plus},
  year = {2020},
  doi = {10.18063/cp.v2i1.270}
}
Kostenlos starten →